Influence of Ukrain on patients with surgically treated breast cancer. Part I. Clinical and laboratory parameters.
Studies were undertaken to evaluate the influence of Ukrain on clinical and laboratory parameters in ten patients with breast cancer treated with the drug in the preoperative phase. The control group was composed of eight patients of similar age and advancement of the disease who did not receive Ukrain before mastectomy. Data from the present studies indicate that the drug is distinctly helpful from the surgical viewpoint by increasing tumour hardness and enlargement of metastatic lymph nodes. Furthermore, treatment with it is fully safe, with no side effects or allergic reactions.
Medical Institute, Grodno, Belarus.
K N
KN
Uglyanica
K A
KA
Fomin
L I
LI
Nefyodov
J W
JW
Nowicky
W J
WJ
Brzosko
A
A
Jankowski
D000470:Alkaloids / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001600:Berberine Alkaloids; D001943:Breast Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000601:surgery*; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006403:Hematologic Tests; D006801:Humans; D008875:Middle Aged; D010617:Phenanthridines
D000470:Alkaloids; D000970:Antineoplastic Agents; D001600:Berberine Alkaloids; D010617:Phenanthridines; C060921:ukrain